Home > Products > B Cell Lymphoma A20-HL Idiotype & CD3 > Recombinant Anti-B Cell Lymphoma A20-HL Idiotype x Anti-CD3 Bispecific Antibody (Minibody)

Recombinant Anti-B Cell Lymphoma A20-HL Idiotype x Anti-CD3 Bispecific Antibody (Minibody)  (CAT#: MiniB-015)

Recombinant Anti-B cell lymphoma A20-HL Idiotype x Anti-CD3 Bispecific Antibody (Minibody) is designed to be expressed as the anti-B cell lymphoma A20-HL Idiotype scFv fused to N-terminus of Knob-CH3 domain and the anti-CD3 scFv to the Hole-CH3 domain, or vice versa. The CH3 domains are further stabilized by C-terminal disulfide bonds. This BsAb can block cell adhesion. It is designed for the research of B cell lymphoma therapy.
Datasheet INQUIRY

Specifications

Targets
B Cell Lymphoma A20-HL Idiotype & CD3
Type
Minibody
Species Reactivity
Mouse
Application
FuncS; Promising therapeutic agent
Related Disease
B cell lymphoma
Host Animal 1
Rat
Host Animal 2
Mouse

Targets

Target 1
B Cell Lymphoma A20-HL Idiotype
Alternative Names
B cell lymphoma A20-HL Idiotype; B cell lymphoma; A20-HL ; Idiotype; Id
Target 2
CD3
Gene ID
UniProt ID
Alternative Names
CD3; CD3E; CD3e molecule; Cluster of differentiation 3; CD3e molecule, epsilon (CD3-TCR complex); T3E; TCRE; IMD18; T-cell surface glycoprotein CD3 epsilon chain; CD3-epsilon; T-cell surface antigen T3/Leu-4 epsilon chain; CD3e antigen, epsilon polypeptide (TiT3 complex); T-cell antigen receptor complex, epsilon subunit of T3; AI504783
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

See other bsAb targets related to "CD3"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-B Cell Lymphoma A20-HL Idiotype x Anti-CD3 Bispecific Antibody (Minibody) (MiniB-015). Click the button below to contact us or submit your feedback about this product.